DK158972C - Farmaceutiske formuleringer indeholdende benzothiophenderivater - Google Patents

Farmaceutiske formuleringer indeholdende benzothiophenderivater

Info

Publication number
DK158972C
DK158972C DK434884A DK434884A DK158972C DK 158972 C DK158972 C DK 158972C DK 434884 A DK434884 A DK 434884A DK 434884 A DK434884 A DK 434884A DK 158972 C DK158972 C DK 158972C
Authority
DK
Denmark
Prior art keywords
derivatives
benzothiophender
formulas containing
pharmaceutical formulas
pharmaceutical
Prior art date
Application number
DK434884A
Other languages
English (en)
Other versions
DK434884A (da
DK158972B (da
DK434884D0 (da
Inventor
Peter Peck Koh Ho
Quentin Francis Soper
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK434884D0 publication Critical patent/DK434884D0/da
Publication of DK434884A publication Critical patent/DK434884A/da
Publication of DK158972B publication Critical patent/DK158972B/da
Application granted granted Critical
Publication of DK158972C publication Critical patent/DK158972C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Seal Device For Vehicle (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
DK434884A 1983-09-13 1984-09-12 Farmaceutiske formuleringer indeholdende benzothiophenderivater DK158972C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/531,802 US4552891A (en) 1983-09-13 1983-09-13 Benzothiophene derivatives
US53180283 1983-09-13

Publications (4)

Publication Number Publication Date
DK434884D0 DK434884D0 (da) 1984-09-12
DK434884A DK434884A (da) 1985-03-14
DK158972B DK158972B (da) 1990-08-13
DK158972C true DK158972C (da) 1991-01-07

Family

ID=24119104

Family Applications (1)

Application Number Title Priority Date Filing Date
DK434884A DK158972C (da) 1983-09-13 1984-09-12 Farmaceutiske formuleringer indeholdende benzothiophenderivater

Country Status (18)

Country Link
US (1) US4552891A (da)
EP (1) EP0139464B1 (da)
JP (1) JPS6084221A (da)
AT (1) ATE38036T1 (da)
AU (1) AU563650B2 (da)
CA (1) CA1229047A (da)
CY (1) CY1513A (da)
DE (2) DE3474662D1 (da)
DK (1) DK158972C (da)
GB (1) GB2146527B (da)
HK (1) HK38990A (da)
IL (1) IL72928A (da)
IT (1) IT1176702B (da)
MY (1) MY101614A (da)
NZ (1) NZ209516A (da)
PH (1) PH21102A (da)
SG (1) SG74789G (da)
ZA (1) ZA847193B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0253650A3 (en) * 1986-07-18 1989-09-13 Eli Lilly And Company Improvements relating to benzothiophene derivatives
GB8816519D0 (en) * 1987-07-23 1988-08-17 Ici Plc Antibiotic compounds
US4863923A (en) * 1988-07-01 1989-09-05 Eli Lilly And Company Method of inhibiting superoxide release
EP0915090A1 (en) * 1992-09-10 1999-05-12 Eli Lilly And Company Compounds useful as hypoglycemic agents and for treating Alzheimer's disease
US6251928B1 (en) * 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6132757A (en) * 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6426084B1 (en) * 2000-06-19 2002-07-30 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
EP1212089B1 (en) 1999-08-21 2006-03-22 ALTANA Pharma AG Synergistic combination of roflumilast and salmeterol
US6458804B1 (en) 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6562838B2 (en) * 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US20030096748A1 (en) * 2001-06-04 2003-05-22 The Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
US7041677B2 (en) * 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
US7208628B2 (en) * 2002-05-13 2007-04-24 Kansas State University Research Foundation Compositions and methods for the treatment of hepatitis C virus infection
US7074893B2 (en) * 2002-06-03 2006-07-11 Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
MXPA05010373A (es) 2003-04-01 2005-12-05 Applied Research Systems Inhibidores de fosfodiesterasas en infertilidad.
US20050089558A1 (en) * 2003-10-28 2005-04-28 Alamo Pharmaceuticals, Llc Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
WO2007098010A2 (en) * 2006-02-17 2007-08-30 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Improved low molecular weight myc-max inhibitors
US10494405B2 (en) 2015-05-15 2019-12-03 The Regents Of The University Of Michigan Methods and compositions for the treatment of arthritis
AU2018366022B2 (en) 2017-11-07 2024-05-16 The Regents Of The University Of Michigan Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH508615A (de) * 1968-05-30 1971-06-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen heterocyclischen Carbonsäuren
US4101668A (en) * 1977-05-10 1978-07-18 Bristol-Myers Company Antiosteoporotic agents

Also Published As

Publication number Publication date
GB2146527A (en) 1985-04-24
DE3433475C2 (da) 1992-12-24
DK434884A (da) 1985-03-14
EP0139464B1 (en) 1988-10-19
GB2146527B (en) 1987-05-20
IT8422626A0 (it) 1984-09-12
ATE38036T1 (de) 1988-11-15
PH21102A (en) 1987-07-16
AU563650B2 (en) 1987-07-16
DK158972B (da) 1990-08-13
DE3474662D1 (en) 1988-11-24
JPS6084221A (ja) 1985-05-13
DK434884D0 (da) 1984-09-12
EP0139464A1 (en) 1985-05-02
IT1176702B (it) 1987-08-18
IT8422626A1 (it) 1986-03-12
MY101614A (en) 1991-12-17
IL72928A0 (en) 1984-12-31
AU3192084A (en) 1985-03-21
CY1513A (en) 1990-08-03
SG74789G (en) 1990-04-20
CA1229047A (en) 1987-11-10
GB8423081D0 (en) 1984-10-17
HK38990A (en) 1990-05-25
DE3433475A1 (de) 1985-03-28
NZ209516A (en) 1987-01-23
US4552891A (en) 1985-11-12
IL72928A (en) 1987-10-20
ZA847193B (en) 1986-04-30

Similar Documents

Publication Publication Date Title
DK158972C (da) Farmaceutiske formuleringer indeholdende benzothiophenderivater
FI830958A7 (fi) Koostumuksia terapeuttista tai diagnostista käyttöä varten ja terapeuttinen käsittelymenetelmä.
IT8447911A1 (it) Apparecchiatura per il trattamento di bottiglia e simili.
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
FI830959A7 (fi) Koostumuksia terapeuttista tai diagnotista käyttöä varten ja terapeuttinen käsittelymenetelmä.
FI891986A0 (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
NO881436D0 (no) Fremgangsmaate for matriksbehandling av en oljebroenn.
DK585984A (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
EP0151646A4 (en) Sizing agent composition and method of using the same.
DE3462129D1 (de) Terphenyl derivatives
IT8219457A0 (it) Impiego terapeutico di derivati (1-cinnamoil oppure 1-fenetil-carbonil)piperazinici.
EP0253650A3 (en) Improvements relating to benzothiophene derivatives
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
IT8020156A0 (it) Metodo per la sterilizzazione dimateriali.
IT1217262B (it) Procedimento di preparazione dei filari per viti e dispositivi preposti all'attuazione di tale procedimento
NO900544D0 (no) Fremgangsmaate og apparat for forbedring av ben-heling.
NO892660L (no) Fremgangsmaate for reendotelialisering av kar-innsider.
IT8422685A0 (it) Composizione farmaceutica eprocedimento per il trattamento di eccetazione psicomotoria.
IT8034030V0 (it) Procedimento di preparazione dei filari per viti e dispositivi preposti all'attuazione di tale procedimento.
NO871797D0 (no) Fremgangsmaate og anordning for anbringelse av blindnagler.
NO830614L (no) Fremgangsmaate for behandling av glaukom.
DK15286D0 (da) Epoxider og anvendelsen heraf som mellemprodukt

Legal Events

Date Code Title Description
PBP Patent lapsed